TY - JOUR AU - Pettitt, A. R. AU - Jackson, R. AU - Carruthers, S. AU - Dodd, J. AU - Dodd, S. AU - Oates, M. AU - Johnson, G. G. AU - Schuh, A. AU - Matutes, E. AU - Dearden, C. E. PY - 2012 DA - 2012// TI - Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 Trial JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.35.9695 DO - 10.1200/JCO.2011.35.9695 ID - Pettitt2012 ER - TY - JOUR AU - Hallek, M. AU - Cheson, B. D. AU - Catovsky, D. AU - Caligaris-Cappio, F. AU - Dighiero, G. AU - Dohner, H. AU - Hillmen, P. AU - Keating, M. J. AU - Montserrat, E. AU - Rai, K. R. PY - 2008 DA - 2008// TI - Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the international workshop on chronic lymphocytic leukemia updating the national cancer institute-working group 1996 guidelines JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-06-093906 DO - 10.1182/blood-2007-06-093906 ID - Hallek2008 ER - TY - JOUR AU - Simon, R. PY - 1989 DA - 1989// TI - Optimal two-stage designs for phase II clinical trials JO - Control Clin Trials VL - 10 UR - https://doi.org/10.1016/0197-2456(89)90015-9 DO - 10.1016/0197-2456(89)90015-9 ID - Simon1989 ER - TY - JOUR AU - Simon, R. AU - Wittes, R. E. AU - Ellenberg, S. S. PY - 1985 DA - 1985// TI - Randomized phase II clinical trials JO - Cancer Treat Rep VL - 69 ID - Simon1985 ER - TY - JOUR AU - Jung, S. H. AU - George, S. L. PY - 2009 DA - 2009// TI - Between-arm comparisons in randomized phase II trials JO - J Biopharma Stat VL - 19 UR - https://doi.org/10.1080/10543400902802391 DO - 10.1080/10543400902802391 ID - Jung2009 ER - TY - JOUR AU - Rubinstein, L. V. AU - Korn, E. L. AU - Freidlin, B. AU - Hunsberger, S. AU - Ivy, S. P. AU - Smith, M. A. PY - 2005 DA - 2005// TI - Design issues of randomized phase II trials and a proposal for phase II screening trials JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.01.149 DO - 10.1200/JCO.2005.01.149 ID - Rubinstein2005 ER - TY - JOUR AU - Estey, E. H. AU - Thall, P. F. PY - 2003 DA - 2003// TI - New designs for phase 2 clinical trials JO - Blood VL - 102 UR - https://doi.org/10.1182/blood-2002-09-2937 DO - 10.1182/blood-2002-09-2937 ID - Estey2003 ER - TY - JOUR AU - Thall, P. F. AU - Simon, R. AU - Ellenberg, S. S. PY - 1988 DA - 1988// TI - 2-stage selection and testing designs for comparative clinical-trials JO - Biometrika VL - 75 UR - https://doi.org/10.1093/biomet/75.2.303 DO - 10.1093/biomet/75.2.303 ID - Thall1988 ER - TY - JOUR AU - Liu, P. Y. AU - LeBlanc, M. AU - Desai, M. PY - 1999 DA - 1999// TI - False positive rates of randomized phase II designs JO - Control Clin Trials VL - 20 UR - https://doi.org/10.1016/S0197-2456(99)00009-4 DO - 10.1016/S0197-2456(99)00009-4 ID - Liu1999 ER - TY - JOUR AU - Sargent, D. J. AU - Goldberg, R. M. PY - 2001 DA - 2001// TI - A flexible design for multiple armed screening trials JO - Stat Med VL - 20 UR - https://doi.org/10.1002/sim.704 DO - 10.1002/sim.704 ID - Sargent2001 ER - TY - JOUR AU - Jung, S. H. AU - Lee, T. AU - Kim, K. AU - George, S. L. PY - 2004 DA - 2004// TI - Admissible two-stage designs for phase II cancer clinical trials JO - Stat Med VL - 23 UR - https://doi.org/10.1002/sim.1600 DO - 10.1002/sim.1600 ID - Jung2004 ER - TY - BOOK AU - Cook, J. PY - 2005 DA - 2005// TI - Multc Lean Statistical Tutorial PB - Department of Biostatistics and Applied Mathematics, University of Texas M. D. Anderson Cancer Center CY - USA ID - Cook2005 ER - TY - BOOK AU - Seshan, V. E. PY - 2012 DA - 2012// TI - clinfun: Clinical Trial Design and Data Analysis Functions. (R package version 1.0.3.) ID - Seshan2012 ER - TY - JOUR AU - Chen, T. T. PY - 1997 DA - 1997// TI - Optimal three-stage designs for phase II cancer clinical tribes JO - Stat Med VL - 16 UR - https://doi.org/3.0.CO;2-1 DO - 3.0.CO;2-1 ID - Chen1997 ER - TY - CHAP AU - Liu, P. Y. AU - Moon, J. AU - LeBlanc, M. ED - Crowley, J. ED - Hoering, A. PY - 2012 DA - 2012// TI - Phase II selection designs BT - Handbook of Statistics in Clinical Oncology. Third edition UR - https://doi.org/10.1201/b11800-13 DO - 10.1201/b11800-13 ID - Liu2012 ER - TY - JOUR AU - Case, L. AU - Morgan, T. PY - 2003 DA - 2003// TI - Design of phase II cancer trials evaluating survival probabilities JO - BMC Med Res Methodol VL - 3 UR - https://doi.org/10.1186/1471-2288-3-6 DO - 10.1186/1471-2288-3-6 ID - Case2003 ER - TY - JOUR AU - Liu, P. Y. AU - Dahlberg, S. AU - Crowley, J. PY - 1993 DA - 1993// TI - Selection designs for pilot-studies based on survival JO - Biometrics VL - 49 UR - https://doi.org/10.2307/2532552 DO - 10.2307/2532552 ID - Liu1993 ER - TY - JOUR AU - Bryant, J. AU - Day, R. PY - 1995 DA - 1995// TI - Incorporating toxicity considerations into the design of two-stage phase II clinical trials JO - Biometrics VL - 51 UR - https://doi.org/10.2307/2533268 DO - 10.2307/2533268 ID - Bryant1995 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2288/13/87/prepub UR - http://www.biomedcentral.com/1471-2288/13/87/prepub ID - ref19 ER -